CD70-directed allogeneic CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD70-directed allogeneic CAR-T cells, covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression [EARLY_Phase 1]